Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: Insights and challenges from 10 years at the psychopharmacology-molecular biology interface

Psychopharmacology

Volumn 181, Issue 4, 2005, Pages 611-638

  Waddington, John L ^a   O'Tuathaigh, Colm ^a   O'Sullivan, Gerard ^a   Tomiyama, Katsunori ^b   Koshikawa, Noriaki ^b   Croke, David T ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b NIHON UNIVERSITY   (Japan)

Author keywords

'Knockout'; Adenylyl cyclase; Behavioural phenotype; DARPP 32; Dopamine D1, D2, D3, D4 and D5 receptor subtypes; Ethogram; G olf; G 7; Orofacial movements; PKA; Transgenic

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR;

GENE MUTATION; GENE TARGETING; GENETIC TRANSDUCTION; LABORATORY TEST; METHODOLOGY; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; PSYCHOPHARMACOLOGY; REVIEW; SIGNAL TRANSDUCTION; TRANSGENICS;

ADENYLATE CYCLASE; ANIMALS; AROUSAL; DNA MUTATIONAL ANALYSIS; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, GENETIC; MOTOR ACTIVITY; PHENOTYPE; PSYCHOMOTOR PERFORMANCE; RATS; RECEPTORS, DOPAMINE; SIGNAL TRANSDUCTION;

EID: 25844440753     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0058-8     Document Type: Review

References (181)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci U S A 93:1945-1949
2. Adachi K, Hasegawa M, Fujita S, Lee J, Cools AR, Waddington JL, Koshikawa N (2003) Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors. Eur J Pharmacol 473:47-54
3. Adams MR, Brandon EP, Chartoff EH, Idzerda RL, Dorsa DM, McKnight GS (1997) Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. Proc Natl Acad Sci U S A 94:12157-12161
4. Aldridge JW, Berridge KC (1998) Coding of serial order by neostriatal neurons: a "natural action" approach to movement sequence. J Neurosci 18:2777-2787
5. 1 receptor antagonist in primate cells and interacts with other receptors. Eur J Pharmacol 364:33-41
6. 1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213:259-267
7. 4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol Psychiatry 9:718-726
8. 2 receptors. Nature 377:424-428
9. Balogh SA, McDowell CS, Stavnezer AJ, Denenberg VH (1999) A behavioral and neuroanatomical assessment of an inbred substrain of 129 mice with behavioral comparisons to C57BL/6J mice. Brain Res 836:38-48
10. 5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J Neurosci 23:816-825
11. Becker JB (1999) Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64:803-812
12. Belluscio L, Gold GH, Nemes A, Axel R (1998) Mice deficient in G (olf) are anosmic. Neuron 20:69-81
13. 1 agonists. Synapse 37:194-204
14. Betancur C, Lepee-Lorgeoux I, Cazillis M, Accili D, Fuchs S, Rostene W (2001) Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice. Neuropsychopharmacology 24:170-182
15. 1 receptor from Apis mellifera: cloning, functional expression, pharmacology, and mRNA localization in the brain. J Neurochem 70:15-23
16. 3 receptor agonists. Neuropharmacology 38:1389-1396
17. 3 knock-out and wild-type mice. Neuropharmacology 38:555-565
18. Boulay D, Depoortere R, Oblin A, Sanger DJ, Schoemaker H, Perrault G (2000) Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. Eur J Pharmacol 391:63-73
19. Brandon EP, Logue SF, Adams MR, Qi M, Sullivan SP, Matsumoto AM, Dorsa DM, Wehner JM, McKnight GS, Idzerda RL (1998) Defective motor behavior and neural gene expression in RIIbeta-protein kinase A mutant mice. J Neurosci 18:3639-3649
20. 1 receptor subtypes in vertebrates. Molecular phylogenetic, pharmacological, and functional criteria defining D1A, D1B, and D1C receptors in European eel Anguilla anguilla. J Biol Chem 272:2778-2787
21. Carter DA (2004) Comprehensive strategies to study neuronal function in transgenic animal models. Biol Psychiatry 55:785-788
22. 5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci 23:8506-8512
23. 2 receptor mutant mice. Psychopharmacology 163:54-61
24. Ciliax BJ, Nash N, Heilman C, Sunahara R, Hartney A, Tiberi M, Rye DB, Caron MG, Niznik HB, Levey AI (2000) Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse 37:125-145
25. Clifford JJ, Waddington JL (2000) Topographically based search for an "Ethogram" among a series of novel D(4) dopamine receptor agonists and antagonists. Neuropsychopharmacology 22:538-544
26. Clifford JJ, Tighe O, Croke DT, Sibley DR, Drago J, Waddington JL (1998) Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax. Neuropharmacology 37:1595-1602
27. Clifford JJ, Tighe O, Croke DT, Kinsella A, Sibley DR, Drago J, Waddington JL (1999) Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase. Neuroscience 93:1483-1489
28. 2 dopamine receptor. Neuropharmacology 39:382-390
29. Clifford JJ, Kinsella A, Tighe O, Rubinstein M, Grandy DK, Low MJ, Croke DT, Waddington JL (2001) Comparative, topographically-based evaluation of behavioural phenotype and specification of D(1)-like:D(2) interactions in a line of incipient congenic mice with D(2) dopamine receptor 'knockout'. Neuropsychopharmacology 25:527-536
30. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002) Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125:584-594
31. 2a receptors to adenylyl cyclase in the striatum. J Neurochem 76:1585-1588
32. Crabbe JC, Wahlsten D, Dudek BC (1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284:1670-1672
33. Crawford CA, Drago J, Watson JB, Levine MS (1997) Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A-deficient mouse. NeuroReport 8:2523-2527
34. Crawley JN (1999) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835:18-26
35. Crawley JN (2000) Designer mice: what's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice. Wiley-Liss, New York, pp 1-7
36. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R (1997) Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 132:107-124
37. Cromwell HC, Berridge KC (1996) Implementation of action sequences by a neostriatal site: a lesion mapping study of grooming syntax. J Neurosci 16:3444-3458
38. Cromwell HC, Berridge KC, Drago J, Levine MS (1998) Action sequencing is impaired in D1A-deficient mutant mice. Eur J Neurosci 10:2426-2432
39. Crusio WE (2004) Flanking gene and genetic background problems in genetically manipulated mice. Biol Psychiatry 56:381-385
40. Daly SA, Waddington JL (1993) Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C. Psychopharmacology 113:45-50
41. 1 receptor. Eur J Pharmacol 199:209-219
42. Deutch AY, Roth RH (1990) The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res 85:367-402
43. Deveney AM, Waddington JL (1995) Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase. Br J Pharmacol 116:2120-2126
44. Diaz-Veliz G, Baeza R, Benavente F, Dussaubat N, Mora S (1994) Influence of the estrous cycle and estradiol on the behavioral effects of amphetamine and apomorphine in rats. Pharmacol Biochem Behav 49:819-825
45. Di Chiara G (2002) Handbook of experimental physiology: dopamine in the CNS 1. Springer, Berlin Heidelberg New York
46. Douhet P, Bertaina V, Durkin T, Calas A, Destrade C (1997) Sex-linked behavioural differences in mice expressing a human insulin transgene in the medial habenula. Behav Brain Res 89:259-266
47. 2 receptor deficient hybrid mice. Brain Res 905:142-151
48. 1 receptor transgenic mice. Exp Neurol 157:169-179
49. Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE, Ooi GT, Grinberg A, Lee EJ, Huang SP et al (1994) Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc Natl Acad Sci U S A 91:12564-12568
50. 1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience 74:813-823
51. 4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci 19:9550-9556
52. 5 receptor knockout mice. Psychopharmacology 169:161-168
53. 4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear. Eur J Neurosci 15:158-164
54. Feng G, Hannan F, Reale V, Hon YY, Kousky CT, Evans PD, Hall LM (1996) Cloning and functional characterization of a novel dopamine receptor from Drosophila melanogaster. J Neurosci 16:3925-3933
55. Festing MF, Simpson EM, Davisson MT, Mobraaten LE (1999) Revised nomenclature for strain 129 mice. Mamm Genome 10:836
56. 2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor. Brain Res 967:191-200
57. Fienberg AA, Greengard P (2000) The DARPP-32 knockout mouse. Brain Res Rev 31:313-319
58. Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281:838-842
59. 2 dopamine receptor knockout mice. Int J Dev Neurosci 20:309-321
60. Gerlai R (1999a) Ethological approaches in behavioral neurogenetic research. In: Crusio WE, Gerlai R (eds) Techniques in the behavioral and neural sciences. Elsevier, Amsterdam, pp 627-635
61. Gerlai R (1999b) Targeting genes associated with mammalian behavior. In: Crusio WE, Gerlai R (eds) Techniques in the behavioral and neural sciences. Elsevier, Amsterdam, pp 381-392
62. Gingrich JA, Hen R (2000) The broken mouse: the role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice. Curr Opin Neurobiol 10:146-152
63. Glickstein SB, Schmauss C (2001) Dopamine receptor functions: lessons from knockout mice. Pharmacol Ther 91:63-83
64. Gold LH (1999) Hierarchical strategy for phenotypic analysis in mice. Psychopharmacology 147:2-4
65. Greengard P (2001) The neurobiology of dopamine signaling. Biosci Rep 21:247-269
66. Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435-447
67. Hatcher JP, Jones DN, Rogers DC, Hatcher PD, Reavill C, Hagan JJ, Hunter AJ (2001) Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res 125:43-47
68. Herve D, Le Moine C, Corvol JC, Belluscio L, Ledent C, Fienberg AA, Jaber M, Studler JM, Girault JA (2001) Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci 21:4390-4399
69. Hirano J, Archer SN, Djamgoz MB (1998) Dopamine receptor subtypes expressed in vertebrate (carp and eel) retinae: cloning, sequencing and comparison of five D1-like and three D2-like receptors. Recept Channels 5:387-404
70. 5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22:10801-10810
71. 5 receptor null mutant mice. Behav Neurosci 115:1129-1144
72. Holmes A, Wrenn CC, Harris AP, Thayer KE, Crawley JN (2002) Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav 1:55-69
73. Holmes A, Lachowicz JE, Sibley DR (2004) Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes. Neuropharmacology 47:1117-1134
74. Homanics GE, Quinlan JJ, Firestone LL (1999) Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines. Pharmacol Biochem Behav 63:21-26
75. 1 dopamine receptors in rat brain. J Neurochem 85:378-386
76. 3 receptors. Neuroscience 91:911-924
77. Kalivas PW, Duffy P (1995) Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 675:325-328
78. Kapsimali M, Vidal B, Gonzalez A, Dufour S, Vernier P (2000) Distribution of the mRNA encoding the four dopamine D(1) receptor subtypes in the brain of the European eel (Anguilla anguilla): comparative approach to the function of D(1) receptors in vertebrates. J Comp Neurol 419:320-343
79. Karasinska JM, George SR, El-Ghundi M, Fletcher PJ, O'Dowd BF (2000) Modification of dopamine D(1) receptor knockout phenotype in mice lacking both dopamine D(1) and D(3) receptors. Eur J Pharmacol 399:171-181
80. Karper PE, De la Rosa H, Newman ER, Krall CM, Nazarian A, McDougall SA, Crawford CA (2002) Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice. Psychopharmacology 159:407-414
81. 4 receptor mutant mice. Psychopharmacology 170:108-114
82. Kazandjian A, Spyraki C, Sfikakis A, Varonos DD (1987) Apomorphine-induced behaviour during the oestrous cycle of the rat. Neuropharmacology 26:1037-1045
83. Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93-96
84. 2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18:3470-3479
85. 5 receptors of rat and human brain. Neuroscience 100:689-699
86. Kido Y, Philippe N, Schaffer AA, Accili D (2000) Genetic modifiers of the insulin resistance phenotype in mice. Diabetes 49:589-596
87. 2 receptor-mediated signaling is lethal in mice. Proc Natl Acad Sci U S A 101:11465-11470
88. 4 receptor-deficient mice, congenic on the C57BL/6J background, are hypersensitive to amphetamine. Synapse 53:131-139
89. Lariviere WR, Chesler EJ, Mogil JS (2001) Transgenic studies of pain and analgesia: mutation or background genotype? J Pharmacol Exp Ther 297:467-473
90. Lee SH, Yajima S, Mouradian MM (1999) Neural cell line-specific regulatory DNA cassettes harboring the murine D1A dopamine receptor promoter. Neurosci Res 34:225-234
91. 2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J Neurosci 22:7931-7940
92. 1 dopamine receptor interacting protein. Science 287:1660-1664
93. 5 knockout mice. Folia Pharmacol Japon 122:25P
94. 2-like interactions: cautionary observations on SK&F 82958 as an anomalous agent. J Psychopharmacol 18:484-495
95. Marchlewska-Koj A, Pochron E, Galewicz-Sojecka A, Galas J (1994) Suppression of estrus in female mice by the presence of conspecifics or by foot shock. Physiol Behav 55:317-321
96. McNamara FN, Clifford JJ, Tighe O, Kinsella A, Drago J, Fuchs S, Croke DT, Waddington JL (2002) Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor "knockout". Synapse 46:19-31
97. McNamara FN, Clifford JJ, Tighe O, Kinsella A, Drago J, Croke DT, Waddington JL (2003) Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype. Neuropsychopharmacology 28:86-99
98. Meyer-Luehmann M, Thompson JF, Berridge KC, Aldridge JW (2002) Substantia nigra pars reticulata neurons code initiation of a serial pattern: implications for natural action sequences and sequential disorders. Eur J Neurosci 16:1599-1608
99. 1 receptor deficient mice. NeuroReport 6:2314-2316
100. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225
101. 1 antagonist SCH 23390. Psychopharmacology 82:409-410
102. Montague DM, Striplin CD, Overcash JS, Drago J, Lawler CP, Mailman RB (2001) Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice. Synapse 39:319-322
103. Montkowski A, Poettig M, Mederer A, Holsboer F (1997) Behavioural performance in three substrains of mouse strain 129. Brain Res 762:12-18
104. 1 dopamine receptor. Proc Natl Acad Sci U S A 93:14928-14933
105. Morice E, Denis C, Giros B, Nosten-Bertrand M (2004) Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Eur J Neurosci 20:120-126
106. 4 receptors in GABAergic neurons of the primate brain. Nature 381:245-248
107. Nadeau JH (2001) Modifier genes in mice and humans. Nat Rev Genet 2:165-174
108. Nally RE, McNamara FN, Clifford JJ, Kinsella A, Tighe O, Croke DT, Fienberg AA, Greengard P, Waddington JL (2003) Topographical assessment of ethological and dopamine receptor agonist-induced behavioral phenotype in mutants with congenic DARPP-32 'knockout'. Neuropsychopharmacology 28:2055-2063
109. Nally RE, Kinsella A, Tighe O, Croke DT, Fienberg AA, Greengard P, Waddington JL (2004) Ethologically based resolution of D2-lilce dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3′,5′-monophosphate-regulated phosphoprotein of 32 kDa "knockout" mutants congenic on the C57BL/6 genetic background. J Pharmacol Exp Ther 310:1281-1287
110. 3 receptor in the morphine-induced rewarding effect and hyperlocomotion. J Neurosci 23:1006-1012
111. Niznik HB, Sugamori KS, Clifford JJ, Waddington JL (2002) D1-like dopamine receptors: molecular biology and pharmacology. In: Di Chiara G (ed) Handbook of experimental pharmacology: dopamine in the CNS 1. Springer, Berlin Heidelberg New York, pp 121-158
112. Oak JN, Oldenhof J, Van Tol HH (2000) The dopamine D(4) receptor: one decade of research. Eur J Pharmacol 405:303-327
113. 4 receptor knockout. Eur Neuropsychopharmacol 14:S41
114. O'Sullivan GJ, Roth BL, Kinsella A, Waddington JL (2004b) SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography. Eur J Pharmacol 486:273-280
115. O'Sullivan GJ, Kinsella A, Sibley DR, Tighe O, Croke DT, Waddington JL (2005) Ethological resolution of behavioural topography and D(1)-like versus D(2)-like agonist responses in congenic D(5) dopamine receptor mutants: Identification of D (5):D(2)-like interactions. Synapse 55:201-211
116. 35S] GTPgammaS to Gq-like proteins stimulated with dopamine D1-like receptor agonists. Neurochem Res 25:759-767
117. Panchalingam S, Undie AS (2001) SKF83959 exhibits biochemical agonism by stimulating [(3S)S]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain. Neuropharmacology 40:826-837
118. Paulus MP, Dulawa SC, Ralph RJ, Mark AG (1999) Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains. Brain Res 835:27-36
119. Phillips TJ, Hen R, Crabbe JC (1999) Complications associated with genetic background effects in research using knockout mice. Psychopharmacology 147:5-7
120. 3 dopamine receptor in a novel environment. Neuropsychopharmacology 28:100-107
121. 1-like dopamine receptor to multiple second messenger pathways by synthetic agonists. J Neurosci 17:6545-6553
122. Reed TM, Repaske DR, Snyder GL, Greengard P, Vorhees CV (2002) Phosphodiesterase IB knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning. J Neurosci 22:5188-5197
123. 5 receptor subtype. Eur J Neurosci 16:2049-2058
124. 4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J Neurochem 80:219-229
125. 4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum. Brain Res 989:35-41
126. Rodgers RJ, Boullier E, Chatzimichalaki P, Cooper GD, Shorten A (2002) Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/ SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour. Physiol Behav 77:301-310
127. Rogers DC, Jones DN, Nelson PR, Jones CM, Quilter CA, Robinson TL, Hagan JJ (1999) Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 105:207-217
128. 1 receptor mediates repetitive jaw movements in rats. Biol Psychiatry 44:1178-1184
129. 4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90:991-1001
130. 4 receptor-deficient mice display cortical hyperexcitability. J Neurosci 21:3756-3763
131. Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L, Mayford M, Lockhart DJ, Barlow C (2000) Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci U S A 97:11038-11043
132. Schinka JA, Letsch EA, Crawford FC (2002) DRD4 and novelty seeking: results of meta-analyses. Am J Med Genet 114:643-648
133. Schwindinger WF, Betz KS, Giger KE, Sabol A, Bronson SK, Robishaw JD (2003) Loss of G protein gamma 7 alters behavior and reduces striatal alpha(olf) level and cAMP production. J Biol Chem 278:6575-6579
134. Seeman P, Nam D, Ulpian C, Liu IS, Tallerico T (2000) New dopamine receptor, D2(Longer), with unique TG splice site, in human brain. Mol Brain Res 76:132-141
135. Seong E, Saunders TL, Stewart CL, Burmeister M (2004) To knockout in 129 or in C57BL/6: that is the question. Trends Genet 20:59-62
136. Sibley DR (1999) New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu Rev Pharmacol Toxicol 39:313-341
137. Sidhu A, Laruelle M, Vernier P (2003) Dopamine receptors and transporters: function, imaging and clinical application. Marcel Dekker, New York
138. Smith DR, Striplin CD, Geller AM, Mailman RB, Drago J, Lawler CP, Gallagher M (1998) Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience 86:135-146
139. Starr MS (1996) The role of dopamine in epilepsy. Synapse 22:159-194
140. Steiner M, Katz RJ, Carroll BJ (1980) Behavioral effects of dopamine agonists across the estrous cycle in rats. Psychopharmacology 71:147-151
141. 3 dopamine receptor-deficient mouse: evidence for reduced anxiety. Physiol Behav 63:137-141
142. 5 receptors. Eur J Neurosci 15:133-142
143. Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G (2000) Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A 97:1856-1860
144. Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P (2003) Diverse psychotomimetics act through a common signaling pathway. Science 302:1412-1415
145. Takada M, Tokuno H, Nambu A, Inase M (1998) Corticostriatal projections from the somatic motor areas of the frontal cortex in the macaque monkey: segregation versus overlap of input zones from the primary motor cortex, the supplementary motor area, and the premotor cortex. Exp Brain Res 120:114-128
146. Tallerico T, Novak G, Liu IS, Ulpian C, Seeman P (2001) Schizophrenia: elevated mRNA for dopamine D2(Longer) receptors in frontal cortex. Mol Brain Res 87:160-165
147. Tan S, Hermann B, Borrelli E (2003) Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter. Int Rev Neurobiol 54:145-197
148. 4 receptors: beyond schizophrenia. J Recept Signal Transduct Res 24:131-147
149. Tecott LH, Wehner JM (2001) Mouse molecular genetic technologies: promise for psychiatric research. Arch Gen Psychiatry 58:995-1004
150. Tomiyama K, McNamara FN, Clifford JJ, Kinsella A, Koshikawa N, Waddington JL (2001) Topographical assessment and pharmacological characterization of orofacial movements in mice: dopamine D(1)-like vs. D(2)-like receptor regulation. Eur J Pharmacol 418:47-54
151. Tomiyama K, McNamara FN, Clifford JJ, Kinsella A, Drago J, Tighe O, Croke DT, Koshikawa N, Waddington JL (2002) Phenotypic resolution of spontaneous and
152. Tomiyama K, Nally R, McNamara F, Clifford J, Kinsella A, Tighe O, Croke DT, Fienberg A, Greengard P, Koshikawa N, Waddington J (2003) The study of the active isomers of SKF 83959 and the role of DARPP-32 on the induction of orofacial movements of the mouse. Jpn J Neuropharmacol 22:362
153. 3 receptor "knockout". Synapse 51:71-81
154. 2 receptor knockout mice. Proc Natl Acad Sci U S A 99:8986-8991
155. 1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253:987-992
156. Undie AS, Friedman E (1994) Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices. J Neurochem 63:222-230
157. Undie AS, Weinstock J, Sarau HM, Friedman E (1994) Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 62:2045-2048
158. Undie AS, Berki AC, Beardsley K (2000) Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways. Neuropharmacology 39:75-87
159. 2 receptors. Nature 408:199-203
160. 3 receptor knock-out mice. Behav Brain Res 130:141-148
161. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614
162. Viggiano D, Ruocco LA, Sadile AG (2003) Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder. Neurosci Biobehav Rev 27:623-637
163. Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101:431-447
164. Waddington JL, O'Boyle KM (1989) Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. Pharmacol Ther 43:1-52
165. 2-like dopamine receptor systems. In: Niznik HB (ed) Dopamine receptors and transporters: pharmacology, structure and function. Marcel Dekker, New York, pp 511-537
166. Waddington JL, Daly SA, Downes RP, Deveney AM, McCauley PG, O'Boyle KM (1995) Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors. Prog Neuro-Psychopharmacol Biol Psychiatry 19:811-831
167. 2-like interactions and effects of targeted gene deletion. In: Jenner P, Demirdamar R (eds) Dopamine receptor subtypes. IOC Press, Amsterdam, pp 45-64
168. Waddington JL, Clifford JJ, McNamara FN, Tomiyama K, Koshikawa N, Croke DT (2001) The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockouts'). Prog Neuro-Psychopharmacol Biol Psychiatry 25:925-964
169. Walther T, Voigt JP, Fink H, Bader M (2000) Sex specific behavioural alterations in Mas-deficient mice. Behav Brain Res 107:105-109
170. 2 long receptor-deficient mice display alterations in striatum-dependent functions. J Neurosci 20: 8305-8314
171. 3 dopamine receptors. Psychopharmacology 167:167-173
172. 1 receptor mutant mice. Cell 79:945-955
173. 1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742
174. 2 receptors. Neuron 19:837-848
175. 3 receptor-selective agonists and antagonists. Synapse 31:210-215
176. 1 receptor. Brain Res 852:198-207
177. Xu R, Hranilovic D, Fetsko LA, Bucan M, Wang Y (2002) Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Mol Psychiatry 7:1075-1082
178. 3 receptor knockout mice. Pharmacol Biochem Behav 76:551-562
179. Zarrindast MR, Bayat A, Shafaghi B (1993) Involvement of dopaminergic receptor subtypes in Straub tail behaviour in mice. Gen Pharmacol 24:127-130
180. Zhang GX, Sasamoto K (1990) Projections of two separate cortical areas for rhythmical jaw movements in the rat. Brain Res Bull 24:221-230
181. 1 receptor signaling. J Neurosci 20:RC91